» Articles » PMID: 26870341

Study of the Biological Features of Cultured γδ T Cells

Overview
Journal Biomed Rep
Specialty Biochemistry
Date 2016 Feb 13
PMID 26870341
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to investigate the biological features of cultured γδ T cells. The γδ T cells were cultured and on different culture days cell proliferation, phenotype, killing activity and the secretion of cytokines were analyzed. Cell numbers were counted by an automated cell counter, phenotype of the cells and cytokines were analyzed by flow cytometry, and killing activities of the cells against gastric cancer SGC-7901 cells were tested using the cell counting kit-8. From days 7 to 14, cultured γδ T cells enter the exponential phase. On day 14, maximum proliferation fold was observed, and on day 10, the maximum specific growth rate µmax was achieved. Flow phenotype cluster of differentiation 3-T-cell receptor γδ of the γδ T cells in the first 7-17 days achieved a higher proportion and showed no significant differences between 10 days. Secretion of the cytokines interferon-γ and tumor necrosis factor-α gradually increased in the first 7-14 days. The maximum was achieved on day 14, and subsequently began to decrease. The cytolytic activity of the γδ T cells to kill the SGC-7901 cells in the first 7-14 days had an improved killing effect, a slight decline from the first 17 days; in the effector cell to target cell (E:T) ratio 20:1, 10:1 and 5:1 conditions, γδ T cells kill SGC-7901 cells more effectively than 1:1 and 1:2. In conclusion, γδ T cells cultured in the first 7-14 days are suitable for clinical transfusion, and the optimal transfusion time is day 10. An E:T ratio >5:1 is preferred.

References
1.
Gao Y, Yang W, Pan M, Scully E, Girardi M, Augenlicht L . Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med. 2003; 198(3):433-42. PMC: 2194096. DOI: 10.1084/jem.20030584. View

2.
Beetz S, Marischen L, Kabelitz D, Wesch D . Human gamma delta T cells: candidates for the development of immunotherapeutic strategies. Immunol Res. 2007; 37(2):97-111. DOI: 10.1007/BF02685893. View

3.
Viey E, Fromont G, Escudier B, Morel Y, Da Rocha S, Chouaib S . Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma. J Immunol. 2005; 174(3):1338-47. DOI: 10.4049/jimmunol.174.3.1338. View

4.
Holtmeier W, Kabelitz D . gammadelta T cells link innate and adaptive immune responses. Chem Immunol Allergy. 2005; 86:151-183. DOI: 10.1159/000086659. View

5.
Carding S, Egan P . Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol. 2002; 2(5):336-45. DOI: 10.1038/nri797. View